Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Mizuho analyst Graig Suvannavejh initiates coverage on Regenxbio (NASDAQ:RGNX) with a Outperform rating and announces Price Target of $22.
Mizuho analyst Graig Suvannavejh initiates coverage on Regenxbio (NASDAQ:RGNX) with a Outperform rating and announces Price Target of $22.